Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Gastrointestinal Pathogen Testing Market Size from 2025 to 2034?
The market size for gastrointestinal pathogen testing has experienced a consistent upsurge in the last few years. It was valued at $4.05 billion in 2024 and is forecasted to escalate to $4.23 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.4%. The historical growth trend was fueled by factors like the rising occurrences of gastrointestinal infections, increased awareness about foodborne diseases, an uptick in travel-related infections due to globalization, the implementation of regulatory policies concerning food safety, an increase in healthcare expenditure, and an escalating demand for rapid and precise diagnostic procedures.
In the forthcoming years, the gastrointestinal pathogen testing market is predicted to witness consistent expansion, reaching an anticipated market size of $4.92 billion in 2029, at a Compound Annual Growth Rate (CAGR) of 3.9%. This anticipated growth over the forecast period is largely due to the increasing incidence of gastrointestinal infections worldwide, heightened awareness about the benefits of early diagnosis and treatment, the growth of healthcare facilities in developing economies, the surging need for point-of-care testing solutions, increased emphasis on food safety regulations, and sustained R&D endeavors. The upcoming trends for the forecast period comprise swifter testing techniques, rising utilization of molecular diagnostic methods, growth of point-of-care testing in unconventional healthcare environments, advancements in automation and robotics for simplified testing procedures, the development of innovative biomarkers for improved pathogen identification, and incorporation of artificial intelligence and machine learning techniques.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp
What External and Internal Drivers Are Contributing to the Growth of theGastrointestinal Pathogen Testing Market?
An increase in foodborne disease incidents is anticipated to spur the expansion of the gastrointestinal pathogen testing market. These are illnesses that occur from ingesting food or drinks that have been contaminated with pathogenic microbes, toxins, or chemical compounds. Listeriosis, viral gastroenteritis, taeniasis, and trichinosis are included in the list of foodborne diseases. The swelling number of foodborne cases can be traced back to several factors, such as shifts in food production, distribution and consumption methods, insufficient food safety precautions, and the effect of climate change on food production. Gastrointestinal testing is crucial in pinpointing the particular pathogens that cause foodborne illnesses, enabling healthcare practitioners to identify the source of gastrointestinal symptoms, decide on suitable treatment, monitor outbreaks, and undertake preventive actions to curb the spreading of foodborne diseases. As an illustration, the UK Health Security Agency, a government agency in the UK, stated in February 2024 that there were 167 listeriosis cases in England and Wales in 2022, up from 160 cases the previous year. Therefore, the escalating frequency of foodborne diseases is fuelling the growth of the gastrointestinal pathogen testing market.
What Segment Types Define the Gastrointestinal Pathogen Testing Market Structure?
The gastrointestinal pathogen testingmarket covered in this report is segmented –
1) By Pathogen Type: Bacteria; Viruses; Parasites
2) By Test Type: Molecular Tests; Culture; Biochemical Tests; Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels; Other Panel Types
4) By End-User: Hospitals; Diagnostic Laboratories; Point-Of-Care; Other End Users
Subsegments:
1) By Bacteria: Salmonella spp.; Escherichia coli; Campylobacter spp.; Shigella spp.; Clostridium difficile; Vibrio spp.; Listeria monocytogenes; Helicobacter pylori; Other Bacterial Pathogens
2) By Viruses: Norovirus; Rotavirus; Enteric Adenovirus; Hepatitis A Virus (HAV); Astrovirus; Other Viral Pathogens
3) By Parasites: Giardia lamblia; Entamoeba histolytica; Cryptosporidium spp.; Trichinella spp.; Toxoplasma gondii; Other Parasitic Pathogens
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Gastrointestinal Pathogen Testing Market?
North America was the largest region in the gastrointestinal pathogen testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Gastrointestinal Pathogen Testing Market?
Key industry players in the gastrointestinal pathogen testing market are aiming to develop innovative solutions, such as metagenomic diagnostic tests, to improve the precision, speed, and thoroughness of gastrointestinal pathogen detection. This next-generation technology is used to examine the genetic material of microbes in a given sample, like blood or stool. For example, Microba Life Sciences, a biotech company from Australia, launched MetaPanel in April 2024. This metagenomic diagnostic test was created to detect an extensive range of gastrointestinal pathogens with high precision. With the capability to cover 175 pathogen targets in a single test, MetaPanel provides a comprehensive solution for healthcare professionals, helping them diagnose both standard and challenging-to-detect infections. It employs next-generation sequencing (NGS) technology to scrutinize a wide range of genetic material in a stool sample, allowing it to spot several potential pathogens, some of which are not usually tested for in standard GI (gastrointestinal) panels.
View the full report here:
What Is the Definition of the Gastrointestinal Pathogen Testing Market?
Gastrointestinal pathogen testing refers to the process of diagnosing infections and diseases resulting from different pathogens impacting the digestive tract, comprising the stomach and intestines. It encompasses examining specimens, such as stool or blood, to pinpoint the particular pathogens causing gastrointestinal symptoms, facilitating the precise diagnosis and treatment of gastrointestinal disorders.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15571
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model